Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:

Similar documents
Trends in HIV prevalence and incidence sex ratios in ALPHA demographic surveillance sites,

Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia

Investing for Impact

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

End TB Strategy top 10 indicators: current status in participant countries

Monitoring top 10 indicators. Philippe Glaziou September 2016

7.5 South-East Asian Region: summary of planned activities, impact and costs

Mathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & James Seddon (Imperial College London)

Principles and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

HIV Drug Resistance Regional Update Eastern & Southern African Region

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

HIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

The INDEPTH TB network a research collaboration on. Christian Wejse Bandim Health Project, Guinea Bissau / Aarhus University, Denmark

Principles of Writing a Paper and getting it published. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium

511,000 (57% new cases) ~50,000 ~30,000

A Call to Action Children The missing face of AIDS

Estimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country,

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine

increased efficiency. 27, 20

Malawi s Option B+ Key Considerations & Progress

Challenge - Advanced HIV in Antiretroviral- Experienced Patients. Esther C. Casas South African Medical Unit Medecins Sans Frontieres

Predictive Value of interferon-gamma release assays for incident active TB disease: A systematic review

SUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION. Supplement to: All-Cause Mortality Reductions from. Measles Catch-Up Campaigns in Africa

TB Disease Prevalence Survey - Progress Report

HIV-1 subtype C in Karonga District, Malawi. Simon Travers

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Analysis of TB prevalence surveys

Latest developments in WHO estimates of TB disease burden

The Impact of Isoniazid Preventive Therapy and Antiretroviral Therapy on Tuberculosis Incidence in Children Living with HIV in Vietnam

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010

Age-Sex Structure for Selected African countries in the early 2000s

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS

ROLLING BACK THE HIV EPIDEMIC: THE CRITICAL ROLE OF THE LABORATORY.

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

Downloaded from:

Fertility of HIV-infected women: insights from Demographic and Health Surveys

Overview of HIV in West and Central Africa

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Tackling the epidemic of chronic noncommunicable disease in sub Saharan Africa: established priorities and new concerns

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE

Prevention targets & scorecard

INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific

Projected Demand for HIV Diagnostic Tests

Dr Ade Fakoya Senior HIV Advisor

Spectrum. Quick Start Tutorial

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Evolving Realities of HIV Treatment in Resource-limited Settings

EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN

Summary of PEPFAR State of Program Area (SOPA): Care & Support

Qian Gao Fudan University

The human immunodeficiency virus/acquired immune

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Mauritius

Women 4 Global Fund Webinar Updates from the Global Fund. 13 th October 2017

in South Africa. Authors Coetzee, D; Hilderbrand, K; Goemaere, E; Matthys, F; Boelaert, M /j x

AIDS in Africa. An Update. Basil Reekie

Second generation HIV surveillance: Better data for decision making

TB Program and Epidemic aka B2B

Sustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014

A smart and doable investment

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

Time to implement: WHO guidelines on TB Preventive Treatment

Multiple choice questions: ANSWERS

Community Health Workers

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

UNAIDS 2013 AIDS by the numbers

Performance of RNTCP NTI Bulletin 2005,41/3&4,

Update on Meningococcal A Vaccine Development and Introduction

Renewing Momentum in the fight against HIV/AIDS

CERVICAL CANCERCONTROL PROGRAMME IN MALAWI OVERVIEW FOR 2015 PROGRAMME PERFORMANCE

Time to Invest: Building the case for investment in contraception

Costing of the Sierra Leone National Strategic Plan for TB

The consequences of age-specific fertility rates and HIV subfertility on national HIV epidemic estimates from antenatal clinic prevalence

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

TB epidemic and progress towards the Millennium Development Goals

SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT -

ACHAP in Botswana. Dr. Jeffrey L. Sturchio President & CEO, Rabin Martin

Direct Clinical Services

AT HIGH RISK OF PROGRESSING TO ACTIVE TB? Senior Lecturer and Consultant Physician University Hospitals of Leicester UK

TB Prevention in PLHIV: Options Other Than Isoniazid. Johns Hopkins Center for Tuberculosis. Research. Richard E. Chaisson, MD

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Lesotho

C R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Botswana

Population Size Estimation

Downloaded from:

HIV Prevention. Recent Advances and Implications for the Caribbean

HIV incidence time trend and characteristics of recent seroconverters in a rural community with high HIV prevalence: South Africa

Estimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009

Microchip Technology. Xuanhong Cheng Materials Science and Engineering

Assessing Tuberculosis Case Fatality Ratio: A Meta- Analysis

Natalie Leon 1*, Catherine Mathews 1,2, Simon Lewin 1,3, Meg Osler 4, Andrew Boulle 4,5 and Carl Lombard 6

Transcription:

Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study

Incidence of SS+ TB (n/100,000/year 400 350 300 250 200 150 100 TB incidence over time HIV ART?? South Africa Zimbabwe Botswana Kenya Malawi Tanzania Senegal 50 Cameroon 0 1990 1995 2000 2005 2010 Benin

Literature Williams & Dye (Science 2003): early start, high coverage and compliance necessary for ART to reduce TB burden in population Studies have suggested Relative incidence of TB lower amongst patients receiving ART (in CD4 strata) Late starters (CD4<100) remain at elevated risk of TB Limitations Most studies are done in intensely supervised study settings not representative of rural Africa Few cases of TB No HIV negative or positive comparison group Effect of ART on TB incidence in wider population

Research Questions What is the relative incidence of TB by HIV/ART status? What is the effect of the ART roll-out on TB What is the effect of the ART roll-out on TB incidence trends in Karonga District?

Karonga Prevention Study TB epidemiological studies since 1985 All TB cases Laboratory tests Demographic information HIV status (from 1988) ART since July 2005 Low level of clinical and laboratory support

Population denominators Adult population size Census in 1988, 1998, 2008 HIV prevalence in population Mathematical model based on population data for HIV prevalence White R.G. et al (EpiInf, 2007) Uptake of ART in population ART clinic registers Person years on ART in Karonga Recently started on ART --> 6 months or less On ART for longer period --> more than 6 months

TB cases Main analysis Only new SS+ pulmonary TB cases since Jan 1986 Aug 2009 (Lab confirmed -at least 1 positive culture or 2 separate smears positive for Mtb) Sensitivity analyses on different TB case populations HIV and ART status From linked KPS database of previously recorded data Missing HIV and/or ART status were imputed using MICE (Multiple imputation using Chained Equations)

Analysis Relative TB incidence (July 2005 Aug 2009) Rate ratios by HIV status Rate ratios By HIV/ART status Incidence trends analysis Piecewise regression to test for change in trend between 1997 2005 and 2005 Aug 2009 periods

Relative incidence (05 09) Observed RR (95% CI) Period and group n py inc Crude Adjusted * Overall 462 633686 73 n.a. n.a. HIV negative 174 567555 31 1 HIV positive 249 66130 377 12.28 (10.12 14.91) 10.89 (8.87 13.36) HIV+ no ART 124 51602 240 1 1 HIV+<=6m ART 29 1635 1774 7.38 (4.93 11.06) 6.41 (4.25 9.67) HIV+ >6m ART 32 4624 692 2.88 (1.95 4.25) 2.46 (1.66 3.67) *RR s adjusted for age group (15-24, 25-34, 35-44, 45-54, >=55) and sex Note: The imputed data show roughly the same results, which suggests that the imputation did not do anything strange or introduce more bias.

Overall

All cases & HIV negative

HIV positive

Change in incidence trend RR express linear annual change in TB incidence, baseline is first year of the period (1997 or 2005). Imputed datasets were used. Groups Annual change 1997 2005 Annual change 2005-2009 P values * IRR (95% CI) IRR (95% CI) Overall 0.93 (0.91 0.95) 1.01 (0.96 1.07) 0.03 HIV negative 0.91 (0.88 0.95) 1.09 (0.99 1.19) 0.005 HIV positive 0.96 (0.93 0.99) 0.99 (0.92 1.07) 0.58 *p-value for change in trend in 2005.

Summary of results Relative incidence High incidence early after initiation ART Decreases with time, but still elevated Incidence trend Decrease until introduction ART, when it plateaus Imputation Does not affect relative incidence estimates Corrects bias in incidence trends

Limitations No CD4 counts Low CD4 at start ART would explain high relative incidences Population estimates are always a bit uncertain HIV estimates Not include effect ART, but fitted new data reasonably well.

Interpretation Well supported DOTS programme controlling TB incidence Area with generalised HIV and moderate TB transmission Advent of ART coincided with plateau in TB incidence Affects HIV positive and HIV negative population Very high risk of TB in HIV patients starting ART (too) late Incidence trends Extra TB cases following roll-out of ART Direct effect on incidence in HIV positive population Indirect effect in HIV negative population Indirect effect difficult to quantify

Implications/Recommendations Start ART earlier Further collaboration/integration of TB and ART programmes Intensified case finding in high risk population of patients receiving ART

Acknowledgements Patients and clinical staff in Malawi KPS colleagues Funders Audience

THANK YOU